XBI
State Street SPDR S&P Biotech ETF
No insider bought or sold State Street SPDR S&P Biotech ETF in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
XBI over the last year
XBI after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Congress
Members reported 3 trades in XBI since 2023.
Every filing
0 insider filings, newest first
No filings on this page.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.